Zdrowie i gospodarka · 07/05/2014

FDA Requests Public Comment on Proposed Collection of Information for Comparative Price Information in Prescription Drug Advertisements

The Food and Drug Administration (FDA) is seeking public comment on a proposed collection of information related to comparative price information in direct-to-consumer and professional prescription drug advertisements. The proposed study aims to investigate the impact of price comparison information in these types of advertisements.